Avalo Therapeutics, Inc. (AVTX)
20.39
+0.65
(+3.29%)
USD |
NASDAQ |
Aug 26, 12:49
Avalo Therapeutics Total Return Level : 19.74 for Aug. 25, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 25, 2026 | 19.74 |
| August 24, 2026 | 19.27 |
| August 21, 2026 | 19.83 |
| August 20, 2026 | 19.82 |
| August 19, 2026 | 20.75 |
| August 18, 2026 | 19.71 |
| August 17, 2026 | 19.95 |
| August 14, 2026 | 19.59 |
| August 13, 2026 | 19.45 |
| August 12, 2026 | 19.55 |
| August 11, 2026 | 19.47 |
| August 10, 2026 | 19.77 |
| August 07, 2026 | 18.32 |
| August 06, 2026 | 18.70 |
| August 05, 2026 | 18.84 |
| August 04, 2026 | 18.53 |
| August 03, 2026 | 18.05 |
| July 31, 2026 | 18.25 |
| July 30, 2026 | 19.39 |
| July 29, 2026 | 19.01 |
| July 28, 2026 | 19.52 |
| July 27, 2026 | 19.50 |
| July 24, 2026 | 18.44 |
| July 23, 2026 | 17.76 |
| July 22, 2026 | 18.15 |
| Date | Value |
|---|---|
| July 21, 2026 | 18.82 |
| July 20, 2026 | 18.21 |
| July 17, 2026 | 19.37 |
| July 16, 2026 | 17.88 |
| July 15, 2026 | 18.55 |
| July 14, 2026 | 18.42 |
| July 13, 2026 | 18.91 |
| July 10, 2026 | 19.21 |
| July 09, 2026 | 19.95 |
| July 08, 2026 | 19.21 |
| July 07, 2026 | 19.25 |
| July 06, 2026 | 19.96 |
| July 02, 2026 | 18.84 |
| July 01, 2026 | 17.29 |
| June 30, 2026 | 18.48 |
| June 29, 2026 | 19.29 |
| June 26, 2026 | 18.20 |
| June 25, 2026 | 18.00 |
| June 24, 2026 | 18.16 |
| June 23, 2026 | 17.83 |
| June 22, 2026 | 17.08 |
| June 18, 2026 | 14.70 |
| June 17, 2026 | 15.40 |
| June 16, 2026 | 14.33 |
| June 15, 2026 | 14.60 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| ACADIA Pharmaceuticals, Inc. | 30.57 |
| Incyte Corp. | 129.72 |
| AbbVie, Inc. | 457.82 |
| Rezolute, Inc. | 5.01 |
| Alnylam Pharmaceuticals, Inc. | 240.08 |